Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.100 | None | 0.974 | 38 | 0 | 1981 | 2019 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
phenotype | 0.100 | None | 0.929 | 14 | 0 | 1985 | 2018 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
phenotype | 0.070 | None | 1.000 | 7 | 2 | 1985 | 2019 | ||||||||
|
SHC binding and spindle associated 1 | 0.606 | 0.654 | 9.4E-08 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 1985 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
peptidylglycine alpha-amidating monooxygenase | 0.542 | 0.692 | 6.9E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
SKI proto-oncogene | 0.503 | 0.808 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1986 | 2010 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.100 | None | 0.964 | 112 | 0 | 1987 | 2020 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 1987 | 2020 | ||||||||
|
ribonuclease A family member 3 | 0.490 | 0.808 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1987 | 2007 | |||||||||
|
CD63 molecule | 0.542 | 0.731 | 1.7E-02 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 1988 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.984 | 62 | 0 | 1989 | 2019 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1989 | 2019 | ||||||||
|
melanoma cell adhesion molecule | 0.514 | 0.731 | 1.6E-04 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 1989 | 2017 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1989 | 2009 | ||||||||
|
eukaryotic translation initiation factor 3 subunit A | 0.592 | 0.769 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 1989 | 2013 | ||||||||
|
Alzheimer disease 12 | 0.711 | 0.538 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | |||||||||
|
CD58 molecule | 0.584 | 0.769 | 0.25 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.956 | 68 | 0 | 1990 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
phenotype | 0.100 | None | 0.979 | 47 | 0 | 1990 | 2019 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 27 | 0 | 1990 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.100 | None | 0.944 | 18 | 0 | 1990 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 1990 | 2019 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
phenotype | 0.100 | None | 0.900 | 10 | 0 | 1990 | 2015 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 1990 | 2018 |